(Q37150461)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Philippe Bousquet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Pascal Demoly

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Giorgio Walter Canonica

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

I Baiardini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

F Braido

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

F Tarantini

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

A Porcu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

GA2LEN

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

T Zuberbier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

660-669

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18445183%20AND%20SRC:MED&resulttype=core&format=json

The allergy epidemic extends beyond the past few decades

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Severity and impairment of allergic rhinitis in patients consulting in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Increased nasal airflow with budesonide compared with desloratadine during the allergy season

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

The effect of Fel d 1-derived T-cell peptides on upper and lower airway outcome measurements in cat-allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

ARIA (Allergic Rhinitis and Its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X

Sleep disturbances in allergic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2008.01649.X